Unraveling Neutrophil-Driven Interferonopathy in Hemophilic Arthropathy: A New Therapeutic Target
Highlight
– Acute joint bleeding in severe hemophilia A triggers type-I interferon signaling in neutrophils, promoting systemic release of neutrophil extracellular traps (NETs).
– NETs contribute directly to the pathogenesis and progression of hemophilic arthropathy.
– Therapeutic inhibition of the type-I interferon receptor reduces NET formation and attenuates joint damage in a factor VIII knockout mouse model.
– Targeting neutrophil-dependent interferonopathy represents a promising novel strategy to mitigate chronic joint damage in hemophilia patients.
Study Background
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.